<DOC>
	<DOCNO>NCT01340690</DOCNO>
	<brief_summary>This study determine nutritional efficacy Polyunsaturated Fatty Acids ( PUFAs ) combination zinc magnesium , child adolescent diagnose Attention Deficit/ Hyperactivity Disorder ( ADHD ) . The nutritional efficacy proven agreement German `` Verordnung über Diätetische Lebensmittel ( DiätV ) '' correspond European Directive 1999/21/EC . This objective reach perform placebo-controlled supplementation study main efficacy criterion also use pivotal study stimulant non-stimulant drug , i.e . treatment difference final visit baseline Attention Deficit Hyperactivity Disorder Rating Scale , Parent Version IV ( ADHDRS-IV ) .</brief_summary>
	<brief_title>Efficacy Study Polyunsaturated Fatty Acids Children Adolescents With Attention Deficit/ Hyperactivity Disorder</brief_title>
	<detailed_description>The syndrome ADHD affect 5-6 % child adolescent worldwide . The hallmarks inattention , impulsivity hyperactivity . Due parent 's fear significant adverse effect cause stimulant non-stimulant therapy high degree child ADHD remain untreated . Recent observational study show ADHD often associate decreased nutritional status certain PUFAs , zinc magnesium might due metabolic disturbance case fatty acid . First interventional study reveal supplementation nutrient may affect ADHD-related disorder might improve certain clinical parameter , concentration . Participants randomly assign receive either nutritional supplement placebo day duration 84 day . Participants come assessment ADHD symptom , compliance assessment secondary outcome variable . Side effect monitor continuously also assess rating scale .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<criteria>Written Informed Consent parent patient ( separately age group 6 11 year 12 17 year ) Children adolescents gender age group 6 17 year Confirmed diagnosis ADHD semistructured clinical interview Kiddie Schedule Affective Disorders Schizophrenia schoolage child ( KSADS ) ADHDRSIVParent Version ( 18ItemScale ) : Investigator Administered Scored ≥24 Sufficient knowledge German language Known hypersensitivity component either verum placebo food All serious internal disease All severe psychiatric disease except oppositional defiant disorder Current intake follow medication : antidepressant psychotropic medication Recent intake ω3 fatty acid supplementation Indication hospitalization Suicidality ( include suicidal thought ) intelligence quotient &lt; 70 Previous medication stimulant within 4 week Placement institution official judicial ruling Lack willingness store transmit pseudonym data accord German regulation Parallel participation another trial , less 4 week ago Patients foreseeable require primary medication methylphenidate study period 12 week</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>ADHD</keyword>
	<keyword>child</keyword>
	<keyword>adolescent</keyword>
	<keyword>Polyunsaturated Fatty Acids</keyword>
	<keyword>ADHDRS - IV</keyword>
</DOC>